131 related articles for article (PubMed ID: 12767572)
21. Changes in Lp(a) lipoprotein and lipid levels after cessation of female sex hormone production and estrogen replacement therapy.
Kim CJ; Ryu WS; Kwak JW; Park CT; Ryoo UH
Arch Intern Med; 1996 Mar; 156(5):500-4. PubMed ID: 8604955
[TBL] [Abstract][Full Text] [Related]
22. Effect of postmenopausal hormone replacement therapy on lipoprotein and homocysteine levels in Chinese women.
Man RY; Ting LK; Fan S; Lau MM; Siow YL; Chung YH; O K
Mol Cell Biochem; 2001 Sep; 225(1-):129-34. PubMed ID: 11716354
[TBL] [Abstract][Full Text] [Related]
23. Changes in nocturnal melatonin secretion in perimenopausal women: correlation with endogenous estrogen concentrations.
Okatani Y; Morioka N; Wakatsuki A
J Pineal Res; 2000 Mar; 28(2):111-8. PubMed ID: 10709973
[TBL] [Abstract][Full Text] [Related]
24. Gonadotropin dynamics in women receiving immediate or delayed transdermal estradiol after oophorectomy.
Kamel EM; Maurer SA; Hochler MG; Hoffman DI; Rebar RW
Obstet Gynecol; 1991 Jul; 78(1):98-102. PubMed ID: 1904568
[TBL] [Abstract][Full Text] [Related]
25. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women.
Balci H; Altunyurt S; Acar B; Fadiloglu M; Kirkali G; Onvural B
Maturitas; 2005 Apr; 50(4):289-93. PubMed ID: 15780528
[TBL] [Abstract][Full Text] [Related]
26. Different effects of oral conjugated equine estrogen and transdermal estrogen replacement therapy on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women.
Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
Circulation; 2002 Oct; 106(14):1771-6. PubMed ID: 12356628
[TBL] [Abstract][Full Text] [Related]
27. The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women.
D'Anna R; Baviera G; Corrado F; Cancellieri F; Crisafulli A; Squadrito F
Acta Obstet Gynecol Scand; 2005 May; 84(5):474-7. PubMed ID: 15842212
[TBL] [Abstract][Full Text] [Related]
28. Effects of estrogen replacement therapy on estrogen receptor expression and immunoregulatory cytokine secretion in surgically induced menopausal women.
Xia X; Zhang S; Yu Y; Zhao N; Liu R; Liu K; Chen X
J Reprod Immunol; 2009 Jul; 81(1):89-96. PubMed ID: 19497624
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the effects of surgical and natural menopause on carotid intima media thickness, osteoporosis, and homocysteine levels.
Özkaya E; Cakir E; Okuyan E; Cakir C; Ustün G; Küçüközkan T
Menopause; 2011 Jan; 18(1):73-6. PubMed ID: 20661165
[TBL] [Abstract][Full Text] [Related]
30. Effects of transdermal and oral hormone replacement therapies on monocyte chemoattractant protein-1 levels: a randomized clinical trial.
Taşçı T; Şükür YE; Özmen B; Atabekoğlu CS; Cengiz SD; Koçbulut E; Berker B; Sönmezer M
Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():50-4. PubMed ID: 24655552
[TBL] [Abstract][Full Text] [Related]
31. [Effects of oral administration of estrogen replacement therapy in surgical menopause].
Bomba-Opoń DA; Niesłuchowska-Frydrych B; Szucka-May H; Kamiński P; Marianowski L
Ginekol Pol; 2001 Dec; 72(12A):1377-82. PubMed ID: 11883282
[TBL] [Abstract][Full Text] [Related]
32. Effects of estrogen replacement therapy on plasma levels of nitric oxide in postmenopausal women.
Cicinelli E; Ignarro LJ; Matteo MG; Galantino P; Schonauer LM; Falco N
Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):334-9. PubMed ID: 9988796
[TBL] [Abstract][Full Text] [Related]
33. Effect of early estrogen replacement therapy on microvascular reactivity in patients after bilateral ovarectomy.
Prázný M; Fait T; Vrablik M
Neuro Endocrinol Lett; 2007 Aug; 28(4):496-501. PubMed ID: 17693976
[TBL] [Abstract][Full Text] [Related]
34. [Systen--transdermal estradiol for substitution following surgical menopause].
Rachev E; Karag'ozov I
Akush Ginekol (Sofiia); 1995; 34(3):74-6. PubMed ID: 8743861
[TBL] [Abstract][Full Text] [Related]
35. Laryngeal cytological aspects in women with surgically induced menopause who were treated with transdermal estrogen replacement therapy.
Caruso S; Roccasalva L; Sapienza G; Zappalá M; Nuciforo G; Biondi S
Fertil Steril; 2000 Dec; 74(6):1073-9. PubMed ID: 11119730
[TBL] [Abstract][Full Text] [Related]
36. Increased plasma homocysteine after menopause.
Hak AE; Polderman KH; Westendorp IC; Jakobs C; Hofman A; Witteman JC; Stehouwer CD
Atherosclerosis; 2000 Mar; 149(1):163-8. PubMed ID: 10704628
[TBL] [Abstract][Full Text] [Related]
37. Effects of low-dose 17-beta-estradiol plus norethisterone acetate and tibolone on fasting plasma homocysteine levels in postmenopausal women.
Kaleli B; Yildirim B; Demir S; Alatas E
Acta Obstet Gynecol Scand; 2003 Dec; 82(12):1107-11. PubMed ID: 14616255
[TBL] [Abstract][Full Text] [Related]
38. Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy.
Ettinger B; Pressman A
Am J Manag Care; 1999 Jun; 5(6):779-85. PubMed ID: 10538456
[TBL] [Abstract][Full Text] [Related]
39. Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users.
Oger E; Alhenc-Gelas M; Plu-Bureau G; Mennen L; Cambillau M; Guize L; Pujol Y; Scarabin P
Thromb Res; 2001 Jan; 101(2):35-43. PubMed ID: 11342204
[TBL] [Abstract][Full Text] [Related]
40. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.
Pasquali R; Vicennati V; Bertazzo D; Casimirri F; Pascal G; Tortelli O; Labate AM
Metabolism; 1997 Jan; 46(1):5-9. PubMed ID: 9005961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
